| The value of monitoring ciclosporin concentration 2 hours post-dose (C2) in dermatology: A prospective cohort study. | |
| | |
MedLine Citation:
|
PMID: 20673153 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Abstract Background: Ciclosporin (CsA) is an effective treatment for several inflammatory dermatoses, including psoriasis and eczema. In contrast to transplantation medicine, dermatologists do not routinely use CsA blood concentrations to guide therapy. Objective: To determine the range of CsA levels at 2 hours after dosing (C2 levels) and whether these C2 levels had any relationship to clinically relevant parameters, such as CsA dose, serum creatinine, blood pressure, PASI (psoriasis area and severity index) or DLQI (dermatology life quality index). Methods: A total of 18 patients on CsA maintenance therapy (cohort 1) and eight patients commencing on CsA (cohort 2) were included in the study. In cohort 1, CsA blood concentrations were measured at 2 hours post-dose on one occasion only, while in cohort 2, C2 levels were performed at baseline and at 4, 8 and 12 weeks after commencing CsA treatment. Results: In cohort 1, a significant relationship between C2 levels and PASI was found. However, no relationship was found between C2 levels and CsA dose, blood pressure, or serum creatinine. In cohort 2, higher C2 levels were associated with lower PASI scores (p < 0.05) and DLQI scores at 4 weeks (p = 0.014). Conclusion: We suggest that C2 levels may be beneficial in patients who are not responding well to CsA treatment in the loading phase. |
| | |
Authors:
|
Ai-Lean Chew; Saqib J Bashir; Atholl Johnston; Jonathan N W N Barker; Catherine H Smith |
Related Documents
:
|
12580993 - Alterations in cyclosporin a pharmacokinetics and metabolism during treatment with st j... 17323793 - Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin a soft g... 3052893 - Prophylaxis in gynaecological and obstetric surgery: a comparative randomised multicent... |
Publication Detail:
|
Type: Journal Article Date: 2010-08-01 |
Journal Detail:
|
Title: The Journal of dermatological treatment Volume: 22 ISSN: 1471-1753 ISO Abbreviation: J Dermatolog Treat Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-03-07 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8918133 Medline TA: J Dermatolog Treat Country: England |
Other Details:
|
Languages: eng Pagination: 79-85 Citation Subset: IM |
Affiliation:
|
Skin Therapy Research Unit, St John's Institute of Dermatology, Guy's and St Thomas' Hospital NHS Trust, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Acitretin revisited in the era of biologics.
Next Document: Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin.